Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stages II-III Breast Cancer × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 29 Lymphoma, Large B-Cell, Diffuse 16 Lymphoma 15 Sarcoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Hodgkin Disease 9 Neoplasm Metastasis 8 Prostatic Neoplasms 7 Lymphoma, Non-Hodgkin 7 Multiple Myeloma 6 Leukemia 6 Burkitt Lymphoma 6 Recurrence 5 Neoplasms 5 Lymphoma, B-Cell 5 Carcinoma, Hepatocellular 5 Ovarian Neoplasms 4 Osteosarcoma 4 Liver Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Sezary Syndrome 2 Sarcoma, Ewing 2

Interventions

Taxes 1 Doxorubicin 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01090128 2017-03-31

NAC

University of Utah

Phase 1 Terminated

Stages II-III Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡